GUGGENHEIM CAPITAL LLC - INSYS THERAPEUTICS INC NEW ownership

INSYS THERAPEUTICS INC NEW's ticker is INSYQ and the CUSIP is 45824V209. A total of 134 filers reported holding INSYS THERAPEUTICS INC NEW in Q1 2015. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of INSYS THERAPEUTICS INC NEW
ValueSharesWeighting
Q1 2016$2,395,000
-53.7%
149,777
-17.0%
0.01%
-46.7%
Q4 2015$5,169,000
-15.1%
180,544
-15.6%
0.02%
-21.1%
Q3 2015$6,085,000
-16.2%
213,824
+5.8%
0.02%
+5.6%
Q2 2015$7,259,000
+17.8%
202,087
+90.6%
0.02%
+20.0%
Q1 2015$6,162,000
+59.7%
106,010
+15.9%
0.02%
+50.0%
Q4 2014$3,858,000
+15.2%
91,498
+6.0%
0.01%
+25.0%
Q3 2014$3,348,000
+9.2%
86,342
-12.0%
0.01%0.0%
Q2 2014$3,065,000
+105.0%
98,140
+129.7%
0.01%
+60.0%
Q3 2013$1,495,00042,7240.01%
Other shareholders
INSYS THERAPEUTICS INC NEW shareholders Q1 2015
NameSharesValueWeighting ↓
Consonance Capital Management LP 3,257,094$92,697,00013.04%
JW Asset Management, LLC 388,346$11,052,0004.00%
Anson Funds Management LP 400,200$11,390,0003.31%
Orbimed Advisors 4,081,800$116,168,0001.17%
SCOPIA CAPITAL MANAGEMENT LP 1,718,487$48,908,0001.05%
Bellevue Asset Management AG 210,000$5,977,0000.98%
NEXT CENTURY GROWTH INVESTORS LLC 788,534$22,441,0000.93%
Rock Springs Capital Management LP 308,000$8,766,0000.71%
JUNCTURE WEALTH STRATEGIES, LLC 18,502$527,0000.43%
B. Riley Wealth Management, Inc. 8,600$244,0000.35%
View complete list of INSYS THERAPEUTICS INC NEW shareholders